DSGN - Design Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DSGN is currently covered by 2 analysts with an average price target of $14. This is a potential upside of $1.76 (14.38%) from yesterday's end of day stock price of $12.24.

Design Therapeutics's activity chart (see below) currently has 27 price targets and 29 ratings on display. The stock rating distribution of DSGN is 75% HOLD and 25% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 43.54% with an average time for these price targets to be met of 312 days.

Highest price target for DSGN is $14, Lowest price target is $14, average price target is $14.

Most recent stock forecast was given by LEONID TIMASHEV from RBC on 10-Mar-2026. First documented stock forecast 20-Apr-2021.

Best performing analysts who are covering DSGN - Design Therapeutics:

Laura Chico Leonid Timashev Yasmeen Rahimi Joseph Schwartz

Currently out of the existing stock ratings of DSGN, 3 are a HOLD (75%), 1 are a BUY (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Mar-2026

$14

$1.88 (15.51%)

$13

6 months 22 days ago
(10-Mar-2026)

6/9 (66.67%)

$4.01 (40.14%)

153

Hold Since 03-Dec-2025

$14

$1.88 (15.51%)

9 months 29 days ago
(03-Dec-2025)

1/3 (33.33%)

$4.23 (43.30%)

147

Hold Since 07-May-2024

$12

$-0.12 (-0.99%)

2 years 4 months 25 days ago
(07-May-2024)

1/4 (25%)

$7.31 (155.86%)

699

Hold Since 14-Nov-2023

$5

$-7.12 (-58.75%)

$6

2 years 10 months 18 days ago
(14-Nov-2023)

3/6 (50%)

$2.71 (118.34%)

247

Show more analysts

Please expand the browser size to see the chart

What is DSGN (Design Therapeutics) average time for price targets to be met?

On average it took 312 days for the stock forecasts to be reached, with an average price target met ratio of 43.54%.

Which analyst most recently updated their price target on DSGN (Design Therapeutics)?

Leonid Timashev

Which analyst has the most public recommendations on DSGN (Design Therapeutics)?

Leonid Timashev works at RBC and has 22 price targets and 14 ratings on DSGN

Which analyst is the currently most bullish on DSGN (Design Therapeutics)?

Leonid Timashev with the highest potential upside of $1.88

Which analyst is the currently most reserved on DSGN (Design Therapeutics)?

Laura Chico with the lowest potential downside of -$7.12
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?